🦟 Malaria: Symptoms, Diagnosis, and Why Early Treatment Matters

Malaria remains one of the most significant public health challenges in India, particularly in rural and forested areas, but also in cities like Hyderabad during the monsoon. It is a parasitic infection spread by the bite of an infected female Anopheles mosquito. Left untreated, certain types of malaria can progress rapidly to severe organ damage and death. Dr. Ravi Sishir Reddy explains the classic symptoms, the different types of malaria, how the diagnosis is confirmed, and the crucial importance of starting treatment early.

1. What Is Malaria?

Malaria is caused by a microscopic parasite of the genus Plasmodium. When an infected mosquito bites a person, it injects the parasites (in the form of sporozoites) into the bloodstream. These travel to the liver, where they multiply silently for 1‑4 weeks, and then re‑enter the blood to invade red blood cells. Inside the red cells, the parasites multiply further until the cells burst, releasing more parasites to infect other cells. This bursting is what causes the classic malarial paroxysm — severe chills, fever, and drenching sweats. Five species of Plasmodium infect humans, but two are responsible for the vast majority of cases in India:

• Plasmodium falciparum: The most dangerous species. It can infect red blood cells of all ages, leading to very high parasite loads, severe anaemia, and life‑threatening complications including cerebral malaria (coma), kidney failure, and respiratory distress. It is responsible for most malaria deaths globally and in India.
• Plasmodium vivax: Historically considered "benign," but now known to cause severe illness in some cases. P. vivax can lie dormant in the liver for months or even years (hypnozoites) and later cause relapses. It predominates in many parts of India.
• Other species like P. ovale and P. malariae are much less common.

2. The Classic Malaria Paroxysm: Chills, Fever, and Sweats

Malaria presents with a characteristic cyclic pattern that corresponds to the bursting of infected red blood cells. This pattern may not be clearly established in the first few days but becomes more distinct as the illness progresses. Each episode has three stages:

• Cold stage (15‑60 minutes): The patient feels intensely cold, has violent, teeth‑chattering shivering (rigors), and the skin becomes pale and goose‑bumped. This is when the parasites are bursting out of the red cells. Temperature begins to rise sharply.
• Hot stage (2‑6 hours): The temperature climbs to 104°F‑106°F (40°C‑41°C). The skin is hot and dry, the face flushed. The patient experiences severe headache, nausea, and often vomiting.
• Sweating stage (2‑4 hours): Profuse, drenching sweats soak the bedclothes. The temperature drops rapidly, and the patient feels exhausted but relieved. They often fall into a deep sleep.

These paroxysms classically occur every 48 hours (tertian fever) with P. vivax and P. ovale, and every 72 hours (quartan fever) with P. malariae. P. falciparum may cause a daily (quotidian) or irregular fever pattern. In between episodes, the patient may feel relatively well — which is deceptive, because the disease is still progressing.

Other common symptoms include severe anaemia (pallor, fatigue, breathlessness), an enlarged spleen (splenomegaly) and liver (hepatomegaly), and in severe falciparum malaria, jaundice (yellowing of the skin and eyes), confusion, seizures, and coma.

3. How Is Malaria Diagnosed?

Prompt and accurate diagnosis is critical. Dr. Reddy outlines the main diagnostic methods, which are available at all major hospitals and diagnostic centres:

• Microscopic examination of blood smears (the gold standard): A drop of the patient's blood is spread on a glass slide, stained with Giemsa stain, and examined under a microscope. Two types of smears are made — a thick smear (which concentrates the parasites to detect their presence) and a thin smear (which allows identification of the specific Plasmodium species and quantification of the parasite load). This test is inexpensive and reliable when performed by a trained technician, but results may take 1‑2 hours.
• Rapid Diagnostic Tests (RDTs): These are simple, dipstick‑type tests that detect specific malaria proteins (antigens) in a finger‑prick blood sample. Results are available in 15‑20 minutes. RDTs can quickly differentiate P. falciparum from other species, which is important for choosing the right drug. They are particularly useful in settings where microscopy is not immediately available, but they are slightly less sensitive than a good blood smear.
• Complete Blood Count (CBC): Often shows low platelets (thrombocytopenia) and anaemia, which support the suspicion of malaria, but a CBC alone cannot diagnose it.

If you have a fever and live in or have traveled to a malaria‑endemic area, your doctor will order a blood smear or RDT. Do not take anti‑malarial drugs empirically without a confirmed diagnosis, as this can mask the true cause of the fever and contribute to drug resistance.

4. Treatment: Artemisinin‑Based Combination Therapy (ACT)

The treatment of malaria depends on the species, the severity of the illness, and the geographical resistance patterns. Dr. Reddy provides a general overview, emphasising that all treatment must be prescribed and supervised by a doctor:

• Uncomplicated P. falciparum malaria: Treated with Artemisinin‑based Combination Therapy (ACT), typically artesunate combined with a partner drug such as sulfadoxine‑pyrimethamine, mefloquine, or lumefantrine. ACTs are highly effective and rapidly clear the parasite from the blood. The exact combination and duration (usually 3 days) are prescribed by the physician according to national guidelines.
• Uncomplicated P. vivax malaria: Treated with chloroquine (in areas where the parasite is still sensitive) plus primaquine. Primaquine is essential because it kills the dormant liver forms (hypnozoites) of P. vivax and P. ovale, preventing relapses. However, primaquine can cause severe haemolysis (red blood cell destruction) in people with G6PD deficiency — an enzyme deficiency common in certain Indian populations. Your doctor will test for G6PD deficiency before prescribing primaquine.
• Severe malaria (with organ dysfunction, coma, or very high parasite load) is a medical emergency requiring hospitalisation for intravenous artesunate, intensive monitoring, and supportive care for complications like renal failure, severe anaemia, and respiratory distress.

Never self‑medicate for malaria. Incomplete treatment promotes drug resistance, and taking primaquine without G6PD testing can be dangerous.

5. When Malaria Becomes Severe: Danger Signs

Severe malaria, most commonly caused by P. falciparum, occurs when the parasite load overwhelms the body and leads to organ failure. Dr. Reddy lists the major manifestations that require immediate hospitalisation:

• Cerebral malaria: The patient becomes confused, agitated, or unconscious. Seizures may occur. This is the deadliest form of malaria.
• Severe anaemia: Haemoglobin drops below 5‑7 g/dL, causing extreme pallor, weakness, and heart failure.
• Acute kidney injury: Urine output drops dramatically; dialysis may be required.
• Acute respiratory distress syndrome (ARDS): Fluid accumulates in the lungs, causing severe breathing difficulty.
• Hypoglycemia: Dangerously low blood sugar, which can be worsened by quinine treatment and high parasite activity.
• Shock and multi‑organ failure.

Any person with malaria who develops altered consciousness, jaundice, severe anaemia, or breathing difficulty must be treated in an intensive care unit. The window for effective treatment can be narrow — hours make the difference between survival and death.

6. Prevention: Mosquito Bite Avoidance and Chemoprophylaxis

• Insecticide‑treated mosquito nets (ITNs): The most cost‑effective prevention method. Sleeping under a long‑lasting insecticide‑treated net reduces malaria transmission by over 50%.
• Indoor residual spraying (IRS): Spraying the inner walls of houses with insecticides kills adult mosquitoes.
• Personal protection: Use mosquito repellents (DEET, picaridin), wear long sleeves and trousers in the evenings and at night (Anopheles mosquitoes are nocturnal feeders), and screen windows and doors.
• Chemoprophylaxis (preventive medication): For travellers visiting high‑risk areas for a short period, prophylactic drugs (like atovaquone‑proguanil or doxycycline) can be prescribed. This is not recommended for residents of endemic areas who have partial immunity, and it must be prescribed and managed by a doctor.
• Malaria vaccine: The RTS,S/AS01 (Mosquirix) vaccine has been approved by WHO for use in children in high‑transmission areas of Africa, but it is not currently part of routine immunisation in India. Research continues on more effective vaccines.